FDA's Medical Device De Novo Reclassification Process

Duration: 60 Minutes
flat 50% off on this webinar
Today, any new medical device that is found not substantially equivalent for a reason other than performance data not previously classified based on risk is "automatically" or "statutorily" classified as a Class III device. This occurs because, by definition, a new device type would not be equivalent to a device type on the market before the 1976 Medical Device Amendments were placed in force or that has since been classified as a Class I or Class II device. This can have many levels of implication to a manufacturer of a low-risk device that suddenly finds themselves in the position of having their device classified as a Class III.
De Novo Reclassification Process
Instructor: Charles H Paul
Product ID: 502304
A device can only be moved out of Class III in this situation only through a reclassification process. The De Novo process provides a possible route to marketing a low risk device type. Unfortunately, this process remains one of the least utilized routes to the marketing of these devices. This webinar will examine and define De Novo and discuss the key elements of this classification process.

Objectives of the Presentation
  • Explain when De Novo process may be used
  • Explain how to gather and submit De Novo Information for FDA review
  • Explain the De Novo pathways
  • Describe the Pre De Novo Submission (PDS) process
  • Define and explain the purpose of the De Novo petition
  • Explain the FDA review process for a De Novo application
Why Should you Attend
A new type of device may be eligible for the de novo process if it has received an NSE determination as a result of a 510(k) submission. The submitter of the 510(k), within thirty (30) days of receipt of an NSE determination, submits a De Novo petition requesting that a risk-based classification determination be undertaken. The petition must include a description of the device with detailed information and the reasons for any recommended classification. The FDA must make a classification determination for the device that is the subject of the petition by written order within sixty (60) days of the request.

If FDA grants the de novo petition, the device is reclassified from Class III into Class I or Class II allowing the device to be then marketed and serve as a predicate device. If the petition is denied, the device remains in Class III and may not be marketed.

This webinar will follow this pathway explaining the process that must be followed to assure the most potential for a successful outcome.

Who will Benefit
Anyone in the medical device industry that has responsibility for the classification of medical devices. Some typical areas and titles include:
  • Regulatory Affairs/Compliance
  • Quality
  • R & D
  • Engineering
  • Quality Engineers
  • Quality Managers
  • Regulatory Specialists
  • Regulatory Managers
  • Compliance Specialists
  • Design and development engineers
  • Industrial designers
  • Risk managers and project managers
  • Medical device manufacturers
  • Marketing
  • CEOs and operations managers for small companies
$375
Recorded Session for one participant
Get life time access with download option!
Book this course
Pay Now
  $500.00 Training CD
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
  $600.00 Training USB Flash Drive
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
For multiple location please contact our customer care team +1-510-857-5896.
How it works
Live Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • The webinar joining link, username and password for joining the webinar will be updated on your OCP Account 24 hours prior to the webinar
  • Presentation handouts in Downloadable PDF format will be updated on your OCP Account 24 hours prior to the live session
  • Login to the audio conference on the scheduled date and time
  • Get answers to your queries through interactive Q&A sessions via chat at the end of the session
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account 24 hours after the completion of the session
  • Please let us know your thoughts and views at the end of the webinar, your valuable feedback will help us improve
Recorded Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • Upon purchase of the recorded session a link will be updated on your OCP Account within 24 hours
  • Please click on the link to access the Recorded Session
  • Presentation handouts in downloadable PDF format will be updated on your OCP Account within 24 hours of the purchase of the product
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account after 48 hours of the product Purchase
  • Please share your valuable Feedback at the end of the session
Instructor Profile:
Charles H. Paul is the President of C. H. Paul Consulting, Inc. - a regulatory, Lean Manufacturing, training, and technical documentation consulting firm. Charles is a management consultant, instructional designer and regulatory consultant and has led C. H. Paul Consulting, Inc. since its inception over 25 years ago. He regularly consults with Fortune 500 pharmaceutical, medical device, and biotechnology firms assisting them in achieving human resource, regulatory, and operational excellence. He is a regular presenter of webinars and on-site seminars in a variety of related subjects from documentation development to establishing compliant preventive maintenance systems. The firm works globally completing projects throughout the EU, UK, South America, and Asia.
View More